VITAMINS & SUPPLEMENTS · GUIDE
Omega-3 and B-Vitamin Trials for Brain Health: What They Found
What randomized trials and meta-analyses of omega-3 fatty acids and B vitamins found for memory and thinking, why results differ, and what the brain scan studies can and cannot show.
Content last updated . This page has not been medically reviewed.
Back to Omega Fatty Acids Explained: Omega-3, Omega-6 and Omega-9Quick answer
Omega-3 fatty acids and B vitamins have been tested more often than most brain supplements. The overall picture is mostly null or small: large trials in older adults with normal thinking found little or no cognitive benefit, while a few pooled analyses report small effects on single measures. This page is information only. It does not tell anyone what to take. Nutrient basics are on the omega-3 evidence by use page and the folate page.
Omega-3 trials
| Study (population, form, length) | What it found | Label |
|---|---|---|
| Cochrane review, 2012: cognitively healthy people aged 60 and over, omega-3 for at least six months | The available trials showed no benefit on cognitive function, and direct evidence on incident dementia was lacking. [1] | No good evidence of benefit |
| VITAL trial, community adults aged 60 and over (mean age about 71): marine omega-3 1 g a day for about 2 to 3 years | No significant effect on a global cognitive score. [2] | No good evidence of benefit |
| Meta-analysis, 2024: 24 studies, 9,660 adults aged 40 and over without dementia, follow-up 3 to 36 months | Possible benefit to executive function that was more notable where background DHA and EPA levels were not very low. [3] | Promising but limited |
| Meta-analysis, 2016: six randomized trials in the elderly | Reported a small statistical reduction in the rate of cognitive decline on the MMSE screening score. [4] | Mixed |
NCCIH's digest summarises that available evidence shows no benefit on the cognitive functioning of older people without dementia. [5] Omega-3 supplements are discussed for other uses on the fish oil page. In the Cochrane review the main side effect was mild gastrointestinal problems. [1]
B vitamin trials
| Study (population, form, length) | What it found | Label |
|---|---|---|
| Cochrane review, 2018: 14 studies, 27,882 cognitively healthy people, mostly over 60 | B vitamin supplements probably have little or no effect on global cognitive function at any time point up to 5 years. [6] | No good evidence of benefit |
| Cochrane review, 2018: people with MCI | B vitamins taken for six to 24 months probably had little or no effect on episodic memory, executive function or speed of processing. [7] | No good evidence of benefit |
| Meta-analysis, 2022: 25 randomized trials plus observational studies | Supports a small benefit on MMSE change (6,155 participants; MD, 0.14, 95%CI 0.04 to 0.23), with the authors linking it to early, long interventions. [8] | Mixed |
| VITACOG: 271 people over 70 with mild cognitive impairment, folic acid, B12 and B6 versus placebo for 24 months | Mean whole-brain atrophy rate per year was 0.76% versus 1.08% on placebo. [9] | Promising but limited (biomarker) |
The pooled analyses disagree because they include different trials and outcomes. The meta-analysis authors themselves describe controversy over whether lowering homocysteine with B vitamins benefits cognitive function. [8] For B12 deficiency, which is a medical condition, see B12 deficiency.
Frequently asked questions
Do omega-3 supplements improve memory in older adults?
In the large trials we read for adults with normal thinking, no significant benefit was found. [1][2]
Do B vitamins slow cognitive decline?
Cochrane found probably little or no effect on global cognition; one 2022 meta-analysis reported a small benefit on a screening score. [6][8]
What did the brain scan trial show?
In VITACOG, brain shrinkage was slower with B vitamins in people with MCI. [9] A scan measure is not the same as better thinking.
Why do reviews disagree?
They pool different trials, populations and outcomes, and the pooled results have wide uncertainty. [3]
Should I ask a clinician before taking either?
Yes, especially with medicines, pregnancy, kidney or liver conditions, or before surgery. [12]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
How to read these trials
Labels: evidence in adequately nourished people, mixed, promising but limited, no good evidence of benefit, insufficient evidence. A B vitamin trial in people with high homocysteine (a blood marker linked to risk in observational research) answers a different question from a trial in people without it. A brain scan measure such as shrinkage rate is a biomarker, not a clinical outcome. Study amounts are described only so you can see what was tested, never as advice.
Limits and uncertainty
Most participants in the Cochrane B vitamin analysis were over 60, and many had cardiovascular disease, so findings may not apply to young adults. [6] Few studies tracked dementia itself. [6][1]
Safety and who should ask first
- Memory change. The NHS says to see a GP rather than self-diagnose memory loss, and to see a GP if you think you may have a B12 or folate deficiency. [10][11]
- Medicines. Ask a pharmacist whether any supplement matters with your medicines. Read omega-3 safety and medication interactions, and ask a pharmacist.
- Pregnancy, children, kidney or liver conditions, surgery. The trials above were not designed to answer these questions. The FDA notes that some supplements can interact with medicines, affect lab tests or be dangerous during surgery. [12]
References
- PubMed abstract: Omega 3 fatty acid for the prevention of cognitive decline and dementia (The Cochrane database of systematic reviews 2012). Read 2026-10-23.
- PubMed abstract: Marine n-3 fatty acids and cognitive change among older adults in the VITAL randomized trial (Alzheimer's & dementia (New York, N. Y.) 2022). Read 2026-10-23.
- PubMed abstract: The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis (BMC medicine 2024). Read 2026-10-23.
- PubMed abstract: Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials (Aging clinical and experimental research 2016). Read 2026-10-23.
- NCCIH: Dietary Supplements and Cognitive Function, Dementia, and Alzheimer's Disease: The Science. Read 2026-10-23.
- PubMed abstract: Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life (The Cochrane database of systematic reviews 2018). Read 2026-10-23.
- PubMed abstract: Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment (The Cochrane database of systematic reviews 2018). Read 2026-10-23.
- PubMed abstract: B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis (Nutrition reviews 2022). Read 2026-10-23.
- PubMed abstract: Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial (PloS one 2010). Read 2026-10-23.
- NHS: Memory loss (amnesia). Read 2026-10-23.
- NHS: Vitamin B12 or folate deficiency anaemia. Read 2026-10-23.
- FDA 101: Dietary Supplements. Read 2026-10-23.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.